These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
300 related items for PubMed ID: 26882862
1. Decreased expression of the type III TGF-β receptor enhances metastasis and invasion in hepatocellullar carcinoma progression. Zhang S, Sun WY, Wu JJ, Gu YJ, Wei W. Oncol Rep; 2016 Apr; 35(4):2373-81. PubMed ID: 26882862 [Abstract] [Full Text] [Related]
2. GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma. Yang Y, Liu Q, Li Z, Zhang R, Jia C, Yang Z, Zhao H, Ya S, Mao R, Ailijiang T, Bao Y, Zhang H. Carcinogenesis; 2018 Jul 03; 39(7):900-910. PubMed ID: 29365054 [Abstract] [Full Text] [Related]
3. A Positive TGF-β/c-KIT Feedback Loop Drives Tumor Progression in Advanced Primary Liver Cancer. Rojas A, Zhang P, Wang Y, Foo WC, Muñoz NM, Xiao L, Wang J, Gores GJ, Hung MC, Blechacz B. Neoplasia; 2016 Jun 03; 18(6):371-86. PubMed ID: 27292026 [Abstract] [Full Text] [Related]
4. Induction of tolerogenic dendritic cells by activated TGF-β/Akt/Smad2 signaling in RIG-I-deficient stemness-high human liver cancer cells. Zhong M, Zhong C, Cui W, Wang G, Zheng G, Li L, Zhang J, Ren R, Gao H, Wang T, Li X, Che J, Gohda E. BMC Cancer; 2019 May 14; 19(1):439. PubMed ID: 31088527 [Abstract] [Full Text] [Related]
5. Reciprocal activation between MMP-8 and TGF-β1 stimulates EMT and malignant progression of hepatocellular carcinoma. Qin G, Luo M, Chen J, Dang Y, Chen G, Li L, Zeng J, Lu Y, Yang J. Cancer Lett; 2016 Apr 28; 374(1):85-95. PubMed ID: 26872724 [Abstract] [Full Text] [Related]
6. Loss of type III transforming growth factor beta receptor expression increases motility and invasiveness associated with epithelial to mesenchymal transition during pancreatic cancer progression. Gordon KJ, Dong M, Chislock EM, Fields TA, Blobe GC. Carcinogenesis; 2008 Feb 28; 29(2):252-62. PubMed ID: 17999987 [Abstract] [Full Text] [Related]
7. Transforming growth factor-β-induced plasticity causes a migratory stemness phenotype in hepatocellular carcinoma. Malfettone A, Soukupova J, Bertran E, Crosas-Molist E, Lastra R, Fernando J, Koudelkova P, Rani B, Fabra Á, Serrano T, Ramos E, Mikulits W, Giannelli G, Fabregat I. Cancer Lett; 2017 Apr 28; 392():39-50. PubMed ID: 28161507 [Abstract] [Full Text] [Related]
8. cPLA2α activates PI3K/AKT and inhibits Smad2/3 during epithelial-mesenchymal transition of hepatocellular carcinoma cells. Fu H, He Y, Qi L, Chen L, Luo Y, Chen L, Li Y, Zhang N, Guo H. Cancer Lett; 2017 Sep 10; 403():260-270. PubMed ID: 28649002 [Abstract] [Full Text] [Related]
9. HCRP1 downregulation promotes hepatocellular carcinoma cell migration and invasion through the induction of EGFR activation and epithelial-mesenchymal transition. Xu J, Zhang X, Wang H, Ge S, Gao T, Song L, Wang X, Li H, Qin Y, Zhang Z. Biomed Pharmacother; 2017 Apr 10; 88():421-429. PubMed ID: 28122307 [Abstract] [Full Text] [Related]
10. Lipocalin-2 negatively modulates the epithelial-to-mesenchymal transition in hepatocellular carcinoma through the epidermal growth factor (TGF-beta1)/Lcn2/Twist1 pathway. Wang YP, Yu GR, Lee MJ, Lee SY, Chu IS, Leem SH, Kim DG. Hepatology; 2013 Oct 10; 58(4):1349-61. PubMed ID: 23696034 [Abstract] [Full Text] [Related]
11. PEG10 is imperative for TGF-β1-induced epithelial‑mesenchymal transition in hepatocellular carcinoma. Zhang M, Sui C, Dai B, Shen W, Lu J, Yang J. Oncol Rep; 2017 Jan 10; 37(1):510-518. PubMed ID: 28004118 [Abstract] [Full Text] [Related]
12. Ectodomain shedding of TβRIII is required for TβRIII-mediated suppression of TGF-β signaling and breast cancer migration and invasion. Elderbroom JL, Huang JJ, Gatza CE, Chen J, How T, Starr M, Nixon AB, Blobe GC. Mol Biol Cell; 2014 Aug 15; 25(16):2320-32. PubMed ID: 24966170 [Abstract] [Full Text] [Related]
13. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma. Shi Y, Qin N, Zhou Q, Chen Y, Huang S, Chen B, Shen G, Jia H. J Transl Med; 2017 Aug 15; 15(1):176. PubMed ID: 28810875 [Abstract] [Full Text] [Related]
14. Type III TGF-β receptor enhances colon cancer cell migration and anchorage-independent growth. Gatza CE, Holtzhausen A, Kirkbride KC, Morton A, Gatza ML, Datto MB, Blobe GC. Neoplasia; 2011 Aug 15; 13(8):758-70. PubMed ID: 21847367 [Abstract] [Full Text] [Related]
15. A tumor-promoting role for soluble TβRIII in glioblastoma. Burghardt I, Schroeder JJ, Weiss T, Gramatzki D, Weller M. Mol Cell Biochem; 2021 Aug 15; 476(8):2963-2973. PubMed ID: 33772427 [Abstract] [Full Text] [Related]
16. Type III TGF-β receptor inhibits cell proliferation and migration in salivary glands adenoid cystic carcinoma by suppressing NF-κB signaling. Xu D, Li D, Lu Z, Dong X, Wang X. Oncol Rep; 2016 Jan 15; 35(1):267-74. PubMed ID: 26531330 [Abstract] [Full Text] [Related]
17. Neuropilin-2 induced by transforming growth factor-β augments migration of hepatocellular carcinoma cells. Wittmann P, Grubinger M, Gröger C, Huber H, Sieghart W, Peck-Radosavljevic M, Mikulits W. BMC Cancer; 2015 Nov 16; 15():909. PubMed ID: 26573807 [Abstract] [Full Text] [Related]
18. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells. Wu WL, Wang WY, Yao WQ, Li GD. Int J Mol Med; 2015 Dec 16; 36(6):1713-9. PubMed ID: 26499886 [Abstract] [Full Text] [Related]
19. Reduced expression of transcriptional intermediary factor 1 gamma promotes metastasis and indicates poor prognosis of hepatocellular carcinoma. Ding ZY, Jin GN, Wang W, Chen WX, Wu YH, Ai X, Chen L, Zhang WG, Liang HF, Laurence A, Zhang MZ, Datta PK, Zhang B, Chen XP. Hepatology; 2014 Nov 16; 60(5):1620-36. PubMed ID: 24954480 [Abstract] [Full Text] [Related]
20. DEPTOR induces a partial epithelial-to-mesenchymal transition and metastasis via autocrine TGFβ1 signaling and is associated with poor prognosis in hepatocellular carcinoma. Chen J, Zhu H, Liu Q, Ning D, Zhang Z, Zhang L, Mo J, Du P, Liu X, Song S, Fan Y, Liang H, Liu J, Zhang B, Chen X. J Exp Clin Cancer Res; 2019 Jun 22; 38(1):273. PubMed ID: 31228948 [Abstract] [Full Text] [Related] Page: [Next] [New Search]